ALLMedicine™ Hyperamylasemia Center

Oct 30th, 2021 - Hyperamylasemia was found in a group of patients with COVID-19 during hospitalization. However, the evolution and the clinical significance of hyperamylasemia in COVID-19, is not well characterized. In this retrospective cohort study, the epidemio...

Aug 26th, 2021 - The clinical significance of postoperative serum pancreatic enzyme elevation after pancreatoduodenectomy is understudied. We hypothesized that elevation in serum enzymes predicts morbidity and mortality after pancreatoduodenectomy. Retrospective r...

Aug 21st, 2021 - Immune checkpoint inhibitors have been shown to be effective for treating many carcinomas. However, the activated immune response may lead to the development of multiple immune-related adverse events, including rare immune-mediated inflammation du...

Jul 15th, 2021 - Over a twenty-year period, we performed 255 ERCP procedures in infants aged up to 1 year. ERCP was indicated in cholestatic infants with suspicion of biliary obstruction. The most common diagnosis was biliary atresia (48%), choledochal cysts (13%)...

Apr 22nd, 2021 - Acute pancreatitis is the most common complication of Endoscopic Retrograde Cholangiopancreatography (ERCP). There was no conclusion on the prevention of Post-ERCP Pancreatitis (PEP) by Lactated Ringer Solution. The purpose of this meta analyses i...

Apr 7th, 2016 - Methods Written informed consent for the endoscopic retrograde cholangiopancreatography is obtained from all patients. Blood culture is performed, and intravenous 3rd generation cephalosporin is administered routinely. Before endoscopic procedure,...

Sep 22nd, 2015 - Hypothesis: Diclofenac, when administered immediately post ERCP in patients at higher risk of developing post-ERCP pancreatitis, will significantly reduce the incidence of this complication. Intervention: All patients undergoing ERCP not having ex...

Apr 2nd, 2021 - Transcript:Keith Flaherty, MD: With ipilimumab and nivolumab now FDA approved, you look at the data that got it across the finish line. It’s a reasonably immature study, but it nailed a couple of points down. The response rate and the progression-...

Aug 14th, 2019 - The US Food and Drug Administration (FDA) approved pretomanid today, a "major" breakthrough treatment for the most drug-resistant tuberculosis (TB) when used in combination with bedaquiline and linezolid. It is only the third TB drug approved by t...

Sep 9th, 2004 - Question What are the acceptable donor criteria for cadaveric pancreas donation? F.R. Calder, Mb ChB Response from Robert J. Stratta, MD Donor selection and organ procurement are paramount to the success of pancreas transplantation. Most heart-bea...

Mar 27th, 2001 - Question What are the donor exclusion criteria, with special reference to fatty pancreas, for pancreas transplantation? Santosh Potdar, MD Response from Robert J. Stratta, MD Donor selection and organ procurement are of paramount importance to the...